Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial - Ruth Wester; Sonja Zweegman; Bronno van der Holt; Marie José Kersten; Edo Vellenga; Marinus van Marwijk-Kooy; Emelie Asselbergs; Okke de Weerdt; Monique C. Minnema; Sarah Lonergan; Antonio Palumbo; Annemiek Broijl; et al. (HemaSphere, 2020)